IDEAYA Biosciences, Inc. SEC filings IDYA
IDEAYA Biosciences, Inc. has 506 filings in SEC EDGAR's recent list, going back to Aug 26, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Nov 3, 2026 | — |
| 424B5 | Prospectus supplement | Jun 9, 2026 | — |
| 424B5 | Prospectus supplement | Jun 8, 2026 | — |
| 424B5 | Prospectus supplement | May 5, 2026 | — |
| S-3ASR | Automatic shelf registration | May 5, 2026 | — |
| S-8 | Employee stock plan registration | Feb 17, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2025 | — |
| S-8 | Employee stock plan registration | Feb 18, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 424B5 | Prospectus supplement | Jul 10, 2024 | — |
| 424B5 | Prospectus supplement | Jul 9, 2024 | — |
| S-8 | Employee stock plan registration | Feb 20, 2024 | — |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| 424B5 | Prospectus supplement | Oct 26, 2023 | — |
| 424B5 | Prospectus supplement | Oct 24, 2023 | — |
| 424B5 | Prospectus supplement | Jun 26, 2023 | — |
| S-3ASR | Automatic shelf registration | Jun 26, 2023 | — |
| 424B5 | Prospectus supplement | Apr 26, 2023 | — |
| 424B5 | Prospectus supplement | Apr 24, 2023 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| 424B5 | Prospectus supplement | Sep 15, 2022 | — |
| 424B5 | Prospectus supplement | Sep 14, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 424B5 | Prospectus supplement | Jul 8, 2021 | — |
| 424B5 | Prospectus supplement | Jul 6, 2021 | — |
| S-8 | Employee stock plan registration | Mar 23, 2021 | — |
| S-3 | Shelf registration | Mar 23, 2021 | — |
| 424B5 | Prospectus supplement | Jan 21, 2021 | — |
| 424B5 | Prospectus supplement | Aug 12, 2020 | — |
| 424B5 | Prospectus supplement | Jun 18, 2020 | — |
| 424B5 | Prospectus supplement | Jun 16, 2020 | — |
| S-3 | Shelf registration | Jun 1, 2020 | — |
| S-8 | Employee stock plan registration | Mar 24, 2020 | — |
| S-8 | Employee stock plan registration | May 28, 2019 | — |
| 424B4 | Prospectus | May 24, 2019 | — |
| S-1/A | Amended registration statement | May 21, 2019 | — |
| S-1/A | Amended registration statement | May 17, 2019 | — |
| S-1/A | Amended registration statement | May 13, 2019 | — |
| S-1 | Registration statement | Apr 26, 2019 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IDYA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1676725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.